| NTNW | NTGW | P value | HTNW | P value | HTGW | P value | P-trend |
---|---|---|---|---|---|---|---|---|
Mildly decreased eGFR | ||||||||
 Number of participants | 4368 | 2784 |  | 1684 |  | 2093 |  |  |
 Model 1a | 1.00 | 1.12 (1.05–1.20) | <  0.001 | 1.16 (1.08–1.25) | <  0.001 | 1.26 (1.18–1.36) | <  0.001 | <  0.001 |
 Model 2b | 1.00 | 1.13 (1.06–1.21) | <  0.001 | 1.16 (1.08–1.26) | <  0.001 | 1.28 (1.19–1.37) | <  0.001 | <  0.001 |
 Model 3c | 1.00 | 1.05 (0.97–1.13) | 0.262 | 1.07 (0.98–1.17) | 0.145 | 1.13 (1.02–1.24) | 0.020 | 0.020 |
Moderately decreased eGFR | ||||||||
 Number of participants | 200 | 260 |  | 99 |  | 226 |  |  |
 Model 1a | 1.00 | 2.07 (1.70–2.53) | <  0.001 | 1.60 (1.25–2.05) | <  0.001 | 2.90 (2.37–3.56) | <  0.001 | <  0.001 |
 Model 2b | 1.00 | 2.08 (1.70–2.54) | <  0.001 | 1.60 (1.25–2.05) | <  0.001 | 2.93 (2.39–3.60) | <  0.001 | <  0.001 |
 Model 3c | 1.00 | 1.81 (1.44–2.27) | <  0.001 | 1.32 (1.00–1.75) | 0.051 | 2.23 (1.70–2.92) | <  0.001 | <  0.001 |
Severely decreased eGFR | ||||||||
 Number of participants | 7 | 10 |  | 6 |  | 7 |  |  |
 Model 1a | 1.00 | 2.01 (0.74–5.48) | 0.173 | 2.79 (0.93–8.34) | 0.066 | 2.31 (0.79–6.78) | 0.129 | 0.084 |
 Model 2b | 1.00 | 2.06 (0.75–5.64) | 0.159 | 2.86 (0.95–8.55) | 0.061 | 2.35 (0.80–6.90) | 0.121 | 0.078 |
 Model 3c | 1.00 | 1.50 (0.48–4.71) | 0.487 | 1.57 (0.45–5.49) | 0.481 | 1.10 (0.28–4.33) | 0.890 | 0.938 |